{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:57:19Z","timestamp":1774022239049,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.leukres.2002.11.001","type":"journal-article","created":{"date-parts":[[2005,5,30]],"date-time":"2005-05-30T11:24:49Z","timestamp":1117452289000},"page":"821-827","source":"Crossref","is-referenced-by-count":12,"title":["Leukemic cell death induced by antithymocyte globulin"],"prefix":"10.1016","volume":"29","author":[{"given":"Ayami","family":"Yoshimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2002.11.001_bib1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/blood.V62.4.883.883","article-title":"Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia","volume":"62","author":"Camitta","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2002.11.001_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJM198301203080301","article-title":"Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial","volume":"308","author":"Champlin","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2002.11.001_bib3","series-title":"Kidney transplantation: principle and practice","first-page":"343","article-title":"Antilymphocyte globulins and monoclonal antibodies","author":"Cosimi","year":"1998"},{"key":"10.1016\/j.leukres.2002.11.001_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V68.3.712.712","article-title":"Biological and immunological characterization of ATG and ALG","volume":"68","author":"Raefsky","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2002.11.001_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00007890-199103000-00024","article-title":"Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins","volume":"51","author":"Bonnefoy-Berard","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.leukres.2002.11.001_bib6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0011-393X(95)85136-4","article-title":"Comparison of antibody specificities of four anti-thymocyte\/anti-lymphocyte globulin products","volume":"56","author":"Tsuge","year":"1995","journal-title":"Curr Therap Res"},{"key":"10.1016\/j.leukres.2002.11.001_bib7","first-page":"2465","article-title":"Objective regressions of T- and B-cell lymphomas in patients following treatment with anti-thymocyte globulin","volume":"42","author":"Fisher","year":"1982","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2002.11.001_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2141.2000.01853.x","article-title":"Effects of antithymocyte globulin on bone marrow CD34+ cells in aplastic anemia and myelodysplasia","volume":"108","author":"Killick","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2002.11.001_bib9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1182\/blood.V83.4.1051.1051","article-title":"Apoptosis induced by polyclonal antilymphocyte globulins in human B-cell lines","volume":"83","author":"Bonnefoy-Berard","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2002.11.001_bib10","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1126\/science.281.5381.1312","article-title":"Caspases: enemies within","volume":"281","author":"Thornberry","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.leukres.2002.11.001_bib11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1083\/jcb.143.5.1353","article-title":"Caspase-independent cell killing by Fas-associated protein with death domain","volume":"143","author":"Kawahara","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.leukres.2002.11.001_bib12","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1126\/science.277.5332.1652","article-title":"Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis","volume":"277","author":"De Maria","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.leukres.2002.11.001_bib13","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.4049\/jimmunol.159.10.4762","article-title":"CD4+ CD8+ thymocytes are preferentially induced to die following CD45 cross-linking, through a novel apoptotic pathway","volume":"159","author":"Lesage","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2002.11.001_bib14","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.4049\/jimmunol.161.7.3375","article-title":"Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes","volume":"161","author":"Deas","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2002.11.001_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/3068","article-title":"PML induces a novel caspase-independent death process","volume":"20","author":"Quignon","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.leukres.2002.11.001_bib16","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/15233","article-title":"CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia","volume":"5","author":"Mateo","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2002.11.001_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0092-8674(91)90614-5","article-title":"The polypeptide encoded by the cDNA for the surface antigen Fas can mediate apoptosis","volume":"66","author":"Itoh","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2002.11.001_bib18","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1016\/S0021-9258(19)50076-X","article-title":"Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor\/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen","volume":"267","author":"Oehm","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2002.11.001_bib19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","article-title":"Molecular cloning and expression of the Fas ligand, a novel member of the tumour necrosis factor family","volume":"75","author":"Suda","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2002.11.001_bib20","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1182\/blood.V91.7.2360","article-title":"Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins","volume":"91","author":"Genestier","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2002.11.001_bib21","first-page":"435","article-title":"Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3","volume":"15","author":"Bonnefoy-Berard","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.leukres.2002.11.001_bib22","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1182\/blood.V84.8.2457.2457","article-title":"Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma","volume":"84","author":"Maloney","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2002.11.001_bib23","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2002.11.001_bib24","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0140-6736(88)90588-0","article-title":"Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H","volume":"2","author":"Hale","year":"1988","journal-title":"Lancet"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212605000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212605000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T10:33:30Z","timestamp":1706265210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212605000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0145212605000408"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2002.11.001","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}